Osteopontin splice variants are differential predictors of breast cancer treatment responses
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Osteopontin splice variants are differential predictors of breast cancer treatment responses ; volume:16 ; number:1 ; day:11 ; month:7 ; year:2016 ; pages:1-12 ; date:12.2016
BMC cancer ; 16, Heft 1 (11.7.2016), 1-12, 12.2016
- Creator
-
Zduniak, Krzysztof
- Contributor
-
Agrawal, Anil
Agrawal, Siddarth
Hossain, Md Monir
Ziolkowski, Piotr
Weber, Georg F.
SpringerLink (Online service)
- DOI
-
10.1186/s12885-016-2484-x
- URN
-
urn:nbn:de:1111-2016071510928
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zduniak, Krzysztof
- Agrawal, Anil
- Agrawal, Siddarth
- Hossain, Md Monir
- Ziolkowski, Piotr
- Weber, Georg F.
- SpringerLink (Online service)
Other Objects (12)
Meta-analysis of Osteopontin splice variants in cancer
RNA blood levels of osteopontin splice variants are cancer markers
Breast cancer risk in papilloma patients: Osteopontin splice variants indicate prognosis
Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients
Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients
Splice variants of RAS—translational significance
Two new splice variants in porcine PPARGC1A
Splice-disrupt genomic variants in prostate cancer
Identification and characterisation of HDGF splice variants and their differential secretion via exosomal microvesicles
New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies
Expression of osteopontin-5 splice variant in the mouse primary and metastatic breast cancer cells
Functional characterization and identification of mouse Rad51d splice variants
Meta-analysis of Osteopontin splice variants in cancer
RNA blood levels of osteopontin splice variants are cancer markers
Breast cancer risk in papilloma patients: Osteopontin splice variants indicate prognosis
Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients
Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients
Splice variants of RAS—translational significance
Two new splice variants in porcine PPARGC1A
Splice-disrupt genomic variants in prostate cancer
Identification and characterisation of HDGF splice variants and their differential secretion via exosomal microvesicles
New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies
Expression of osteopontin-5 splice variant in the mouse primary and metastatic breast cancer cells
Functional characterization and identification of mouse Rad51d splice variants
Meta-analysis of Osteopontin splice variants in cancer
RNA blood levels of osteopontin splice variants are cancer markers
Breast cancer risk in papilloma patients: Osteopontin splice variants indicate prognosis
Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients
Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients
Splice variants of RAS—translational significance
Two new splice variants in porcine PPARGC1A
Splice-disrupt genomic variants in prostate cancer
Identification and characterisation of HDGF splice variants and their differential secretion via exosomal microvesicles
New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies
Expression of osteopontin-5 splice variant in the mouse primary and metastatic breast cancer cells